Retatrutride

Retatrutide is a once-weekly injectable medication being studied for weight loss and metabolic health. It is called a “triple hormone receptor agonist” because it targets three hormone pathways – GIP, GLP-1, and glucagon – which may help regulate appetite, fullness, blood sugar, and energy balance.

Early studies have shown promising weight-loss results, but Retatrutide is still being evaluated in clinical trials and not yet FDA approve. Patients interested in medical weight-loss treatment should speak with a qualified healthcare provider about approved options, safety, eligibility, and ongoing care.

Complimentary Consult

Common Questions

Retatrutide is still being studied in clinical trials, so individual timelines may vary. In studies, some participants experienced changes in appetite, fullness, and weight over time, with weight-loss results typically developing gradually over several months.

In clinical trials, Retatrutide is being studied as a subcutaneous injection, meaning it is injected under the skin. Because it is not currently FDA-approved, it should only be used as part of a properly supervised clinical trial.

Retatrutide is being studied as a once-weekly injectable medication. However, because it is still investigational, dosing and use should only be determined within an approved clinical trial setting.

Retatrutide is designed to work on three hormone pathways that may help regulate appetite, fullness, blood sugar, digestion, and energy balance. Early studies have shown promising weight-loss results, but researchers are still evaluating its long-term safety, effectiveness, and appropriate use.

Retatrutide is still under investigation and has not yet been FDA-approved, so its full safety profile is not fully established. Any product claiming to sell Retatrutide outside of a clinical trial should be avoided, as it may be unregulated, unsafe, or counterfeit.

Common side effects reported in studies have included nausea, diarrhea, vomiting, constipation, decreased appetite, and stomach discomfort. Because Retatrutide is still being studied, patients should only consider it under qualified medical supervision through a clinical trial.

Important

All medications require clinician evaluation and are prescribed only when medically appropriate.

• Weekly dose: 2mg – 12mg
• Weekly dose × 4 weeks
• Supply: 4 weeks

Dose Options

  • 2 mg weekly (8 mg / vial)
  • 4 mg weekly (16 mg / vial)
  • 8 mg weekly (32 mg / vial)
  • 12 mg weekly (48 mg / vial)

Each vial equals one complete 4-week supply, regardless of dose.

  • 100% Online Medical Visits

  • Fast and Discreet Shipping

  • Personalized One on One Coaching

  • Compounded in a Pharmacy Following USP Standards

  • No Hidden Fees

Getting Started

Retatrutides and other drugs require an initial consultation and evaluation. Schedule your complimentary consultation here.

Complimentary Consult

Shauna lost 46 lbs.

Gail lost 50 lbs.

Antonio lost 57 lbs.

“Essence Wellness has completely changed my life! Tami made me feel supported every step of the way – and I finally have the life I always wanted.”

Laura, Encinitas CA

Get Started on Your Path to Wellness, Confidence, and Empowerment. Book a Complimentary Consult Today.